Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Fischer

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Bioorganic & Medicinal Chemistry|October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitorsStuart C Wilson, Butrus Atrash, Clare Barlow, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2021
Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemiaJong Bong Lee, Xiaowei Zang, Atheer Zgair, et al.
Molecular Oncology|October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitorSteven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2020
Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approachChaolong Qin, YenJu Chu, Wanshan Feng, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic systemJong Bong Lee, Atheer Zgair, Jed Malec, et al.
Journal of Medicinal Chemistry|May 21, 2020
Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity <i>in Vivo</i> Mouse ModelChristophe Fromont, Alessio Atzori, Divneet Kaur, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Bioorganic & Medicinal Chemistry|October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitorsStuart C Wilson, Butrus Atrash, Clare Barlow, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2021
Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemiaJong Bong Lee, Xiaowei Zang, Atheer Zgair, et al.
Molecular Oncology|October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitorSteven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2020
Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approachChaolong Qin, YenJu Chu, Wanshan Feng, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic systemJong Bong Lee, Atheer Zgair, Jed Malec, et al.
Journal of Medicinal Chemistry|May 21, 2020
Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity <i>in Vivo</i> Mouse ModelChristophe Fromont, Alessio Atzori, Divneet Kaur, et al.
Pageof 12